---
pmid: '34120018'
title: N-acetylcysteine, xCT and suppression of Maxi-chloride channel activity in
  human placenta.
authors:
- Lofthouse EM
- Manousopoulou A
- Cleal JK
- O'Kelly IM
- Poore KR
- Garbis SD
- Lewis RM
journal: Placenta
year: '2021'
full_text_available: false
doi: 10.1016/j.placenta.2021.05.009
---

# N-acetylcysteine, xCT and suppression of Maxi-chloride channel activity in human placenta.
**Authors:** Lofthouse EM, Manousopoulou A, Cleal JK, O'Kelly IM, Poore KR, Garbis SD, Lewis RM
**Journal:** Placenta (2021)
**DOI:** [10.1016/j.placenta.2021.05.009](https://doi.org/10.1016/j.placenta.2021.05.009)

## Abstract

1. Placenta. 2021 Jul;110:46-55. doi: 10.1016/j.placenta.2021.05.009. Epub 2021
Jun  5.

N-acetylcysteine, xCT and suppression of Maxi-chloride channel activity in human 
placenta.

Lofthouse EM(1), Manousopoulou A(2), Cleal JK(3), O'Kelly IM(4), Poore KR(4), 
Garbis SD(5), Lewis RM(3).

Author information:
(1)Faculty of Medicine, University of Southampton, UK; Institute for Life 
Sciences, University of Southampton, UK. Electronic address: 
e.m.lofthouse@soton.ac.uk.
(2)Faculty of Medicine, University of Southampton, UK; Institute for Life 
Sciences, University of Southampton, UK; Beckman Research Institute, City of 
Hope National Medical Center, Duarte, CA, USA.
(3)Faculty of Medicine, University of Southampton, UK; Institute for Life 
Sciences, University of Southampton, UK.
(4)Faculty of Medicine, University of Southampton, UK.
(5)Faculty of Medicine, University of Southampton, UK; Institute for Life 
Sciences, University of Southampton, UK; Proteome Exploration Laboratory, 
Beckman Institute, Division of Biology and Biological Engineering, California 
Institute of Technology, Pasadena, CA, USA.

INTRODUCTION: Placental oxidative stress features in pregnancy pathologies but 
in clinical trials antioxidant supplementation has not improved outcomes. 
N-acetylcysteine (NAC) stimulates glutathione production and is proposed as a 
therapeutic agent in pregnancy. However, key elements of N-acetylcysteine 
biology, including its cellular uptake mechanism, remains unclear. This study 
explores how the cystine/glutamate transporter xCT may mediate N-acetylcysteine 
uptake and how N-acetylcysteine alters placental redox status.
METHODS: The involvement of xCT in NAC uptake by the human placenta was studied 
in perfused placenta and Xenopus oocytes. The effect of short-term 
N-acetylcysteine exposure on the placental villous proteome was determined using 
LC-MS. The effect of N-acetylcysteine on Maxi-chloride channel activity was 
investigated in perfused placenta, villous fragments and cell culture.
RESULTS: Maternoplacental N-acetylcysteine administration stimulated 
intracellular glutamate efflux suggesting a role of the exchange transporter 
xCT, which was localised to the microvillous membrane of the placental 
syncytiotrophoblast. Placental exposure to a bolus of N-acetylcysteine inhibited 
subsequent activation of the redox sensitive Maxi-chloride channel independently 
of glutathione synthesis. Stable isotope quantitative proteomics of placental 
villi treated with N-acetylcysteine demonstrated changes in pathways associated 
with oxidative stress, apoptosis and the acute phase response.
DISCUSSION: This study suggests that xCT mediates N-acetylcysteine uptake into 
the placenta and that N-acetylcysteine treatment of placental tissue alters the 
placental proteome while regulating the redox sensitive Maxi-chloride channel. 
Interestingly N-acetylcysteine had antioxidant effects independent of the 
glutathione pathway. Effective placental antioxidant therapy in pregnancy may 
require maintaining the balance between normalising redox status without 
inhibiting physiological redox signalling.

Copyright Â© 2021 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.placenta.2021.05.009
PMID: 34120018 [Indexed for MEDLINE]
